Product Name |
Felbamate D4 |
Alternate Names |
Felbamate Stable Isotopes, Stable Isotopes of Felbamate |
CAT No. |
CS-O-03068
|
CAS No. |
106817-52-1 |
Category |
Stable Isotopes |
Stock |
IN-Stock
|
Mol. Wt. |
242.26 g/mol |
Mol. For. |
C₁₁H₁₀D₄N₂O₄
|
Hazardous |
This is a Hazardous Compound
|
COA |
View Sample COA
|
MSDS |
View Sample MSDS
|
Parent API |
Felbamate |
Purity |
Not less than 95% |
Therapeutic |
Anticonvulsants (Anti-Epileptics) |
Smileys |
C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N |
Canonical Smiles |
C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N |
InchIKey |
WKGXYQFOCVYPAC-KXGHAPEVSA-N |
Inchl |
InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)/i6D2,7D2 |
IUPAC |
(3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate |
Controlled |
No |
Shipping |
Free for purchase above 1000$ |
Delivery |
In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
Return |
Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
Ordering |
Place your order online or by email sales@clearsynth.com |
If you find a better price anywhere else we guarantee Price match.
Felbamate D4 is a deuterated isotopologue of Felbamate, a medication used in the treatment of epilepsy. It is a white crystalline powder that is soluble in water and methanol. Felbamate D4 is a stable isotope of Felbamate that is used in pharmacokinetic studies to determine the metabolic fate of the drug in the body.
Felbamate D4 is a broad-spectrum antiepileptic drug that is used to control seizures in patients with epilepsy. It works by increasing the activity of GABA, a neurotransmitter that helps to regulate brain activity. Felbamate D4 is used in combination with other antiepileptic drugs to achieve better seizure control.
The chemical formula of Felbamate D4 is C11H5D4N2O4. It has a molecular weight of 253.27 g/mol. The deuterium substitution in Felbamate D4 is non-radioactive and does not affect the pharmacological properties of the drug.
Felbamate D4 is metabolized in the liver by cytochrome P450 enzymes. It has a half-life of approximately 20 hours and is eliminated from the body primarily through the kidneys. Felbamate D4 is contraindicated in patients with liver or kidney disease, and caution should be exercised when using it in patients with a history of blood disorders.
In conclusion, Felbamate D4 is a deuterated isotopologue of Felbamate that is used in pharmacokinetic studies. It is also a broad-spectrum antiepileptic drug that is used to control seizures in patients with epilepsy. Felbamate D4 is metabolized in the liver and eliminated through the kidneys. It is contraindicated in patients with liver or kidney disease and caution should be exercised when using it in patients with a history of blood disorders.